Laekna, Inc. (HKG:2105)
Hong Kong · Delayed Price · Currency is HKD 7.55
-0.60 (-7.36%)
Jun 18, 2026, 2:03 PM HKT
Laekna Revenue
In the year 2025, Laekna had annual revenue of 106.72M CNY. Laekna had revenue of 102.21M in the half year ending December 31, 2025.
Revenue
106.72M CNY
Revenue Growth
n/a
P/S Ratio
29.06
Revenue / Employee
1.29M CNY
Employees
83
Market Cap
3.45B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 106.72M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 280.00K | 169.00K | 152.25% |
| Dec 31, 2021 | 111.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Qyuns Therapeutics | 897.99M |
| Ocumension Therapeutics | 895.09M |
| Shandong Boan Biotechnology | 873.36M |
| BioDlink International Company | 831.99M |
| Medtide | 634.40M |
| Mirxes Holding Company | 166.32M |
| Guangzhou Innogen Pharmaceutical Group | 146.34M |
| Jacobio Pharmaceuticals Group | 59.56M |